News

More than meets the eye: Researchers uncover the microbial secrets of dry eye

Insights into the ocular microbiome could have implications beyond eye health
Nancy D. Lamontagne
March 26, 2024

Researchers have used advanced sequencing technology to determine how the mix of microbes present in patients with healthy eyes differs from the mix found in patients with dry eye. The new work could lead to improved treatments for various eye problems and for diseases affecting other parts of the body.

Microbial communities in and on our body — collectively referred to as the human microbiota — play an essential role in keeping us healthy. Although many studies have focused on microbial communities in our gut, understanding the microbiota present in other body sites is critical for advancing our knowledge of human health and developing targeted interventions for disease prevention and treatment.

Scientists from Stephen F. Austin State University discovered that people with dry eye have a different mix of microbes in their eyes. The findings could lead to better treatments.
Scientists from Stephen F. Austin State University discovered that people with dry eye have a different mix of microbes in their eyes. The findings could lead to better treatments.

“Once we understand the eye microbiota properly, it will improve disease diagnosis at an early stage,” said research team leader Alexandra Van Kley, a professor at Stephen F. Austin State University in Nacogdoches, Texas. “This knowledge can also serve as a catalyst for developing innovative therapies aimed at preventing and treating ocular disease as well as those that affect the central microbiome site: the gut.”

Pallavi Sharma, a graduate student in Van Kley’s lab, will present the research at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, which will be held March 23–26 in San Antonio.

“Human microbiome research suggests a strong connection between the gut microbiome and the brain and eyes,” said Sharma. “Any alteration in the gut microbiome affects other organs and can lead to disease. Therefore, we are trying to identify patterns of an imbalance between the types of microbes present in a person's ocular microbiome for people with different health problems.”

For the study, the researchers collected eye samples from 30 volunteers using a swab and then performed 16S rRNA sequencing and bioinformatic analysis to determine the microbiome distribution for patients with healthy eyes and those with dry eyes.

The analysis showed that Streptococcus and Pedobacter bacteria species were the most prevalent microbes in healthy eyes while more Acinetobacter species were present in the eye microbiomes of people with dry eye. “We think the metabolites produced by these bacteria are responsible for dry eye conditions,” said Sharma. “We are performing further research to understand the metabolic pathways associated with the Acinetobacter to better understand the disease.”

Next, the researchers would like to explore the gut microbiome of the patients with dry eye to better understand how it related to the eye microbe differences they observed.

Pallavi Sharma will present this research during a poster session from 4:30 to 6:30 p.m. CDT on Tuesday, March 26, in the exhibit hall of the Henry B. González Convention Center (Poster Board No. 277) (abstract). 

Note: Alexandra Van Kley is listed in the Discover BMB schedule as the presenter, but Pallavi Sharma will be presenting this work.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Nancy D. Lamontagne

Nancy D. Lamontagne is a science writer and editor at Creative Science Writing based in Chapel Hill, North Carolina.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Building better tools to decipher the lipidome
Profile

Building better tools to decipher the lipidome

Feb. 11, 2026

Chemical engineer–turned–biophysicist Matthew Mitsche uses curiosity, coding and creativity to tackle lipid biology, uncovering PNPLA3’s role in fatty liver disease and advancing mass spectrometry tools for studying complex lipid systems.

Redefining lipid biology from droplets to ferroptosis
Award

Redefining lipid biology from droplets to ferroptosis

Feb. 5, 2026

James Olzmann will receive the ASBMB Avanti Award in Lipids at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.

Women’s health cannot leave rare diseases behind
Essay

Women’s health cannot leave rare diseases behind

Feb. 4, 2026

A physician living with lymphangioleiomyomatosis and a basic scientist explain why patient-driven, trial-ready research is essential to turning momentum into meaningful progress.

Life in four dimensions: When biology outpaces the brain
Profile

Life in four dimensions: When biology outpaces the brain

Jan. 27, 2026

Nobel laureate Eric Betzig will discuss his research on information transfer in biology from proteins to organisms at the 2026 ASBMB Annual Meeting.

Fasting, fat and the molecular switches that keep us alive
Interview

Fasting, fat and the molecular switches that keep us alive

Jan. 27, 2026

Nutritional biochemist and JLR AE Sander Kersten has spent decades uncovering how the body adapts to fasting. His discoveries on lipid metabolism and gene regulation reveal how our ancient survival mechanisms may hold keys to modern metabolic health.

Redefining excellence to drive equity and innovation
Award

Redefining excellence to drive equity and innovation

Jan. 22, 2026

Donita Brady will receive the ASBMB Ruth Kirschstein Award for Maximizing Access in Science at the ASBMB Annual Meeting, March 7–10, just outside of Washington, D.C.